KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Csx (CSX) Gains from Investment Securities (2016 - 2025)

Csx (CSX) has disclosed Gains from Investment Securities for 15 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 8.04% to $1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 billion, a 2.42% increase, with the full-year FY2025 number at $1.1 billion, up 2.42% from a year prior.
  • Gains from Investment Securities was $1.1 billion for Q4 2025 at Csx, up from -$22.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.1 billion in Q4 2025 to a low of -$348.0 million in Q2 2021.
  • A 5-year average of $155.3 million and a median of $21.0 million in 2024 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: crashed 3263.64% in 2021, then soared 2800.0% in 2022.
  • Csx's Gains from Investment Securities stood at $454.0 million in 2021, then rose by 8.59% to $493.0 million in 2022, then crashed by 98.78% to $6.0 million in 2023, then soared by 16266.67% to $982.0 million in 2024, then rose by 8.04% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CSX's Gains from Investment Securities are $1.1 billion (Q4 2025), -$22.0 million (Q3 2025), and $45.0 million (Q2 2025).